MeSH D010033 - otitis media
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| AbbVie | Clarithromycin | Biaxin |  | 1991-10-31 |  |  |
| Cefdinir | Omnicef |  | 1997-12-04 |  |  | |
| Able Laboratories | Phenazopyridine, Sulfamethoxazole, Trimethoprim | Sulfamethoxazole Trimethoprim Phenazopyridine |  | 2001-06-26 |  |  |
| Ajanta Pharma | Clarithromycin | Clarithromycin |  | 2019-04-25 |  |  |
| Alembic Pharmaceuticals | Azithromycin | Azithromycin |  | 2020-01-28 |  |  |
| Clarithromycin | Clarithromycin |  | 2022-01-31 |  |  | |
| Alkem Laboratories | Cefdinir | Cefdinir |  | 2021-02-19 |  |  |
| Cefpodoxime proxetil | Cefpodoxime Proxetil |  | 2022-05-18 |  |  | |
| Cephalexin | Cephalexin |  | 2010-12-20 |  |  | |
| Cefprozil | Cefprozil |  | 2024-04-09 |  |  | |
| Allergan | Clarithromycin | Clarithromycin |  | 2004-06-24 |  |  |
| Sulfamethoxazole | Sulfamethoxazole |  | 1982-01-01 |  |  | |
| Sulfamethoxazole, Trimethoprim | Sulfamethoxazole Trimethoprim |  | 1984-11-07 |  |  | |
| Alpharma | Sulfamethoxazole, Trimethoprim | Trimeth/sulfa |  | 1988-05-23 |  |  |
| Amneal Pharmaceuticals | Azithromycin | Azithromycin |  | 2018-07-19 |  |  |
| Sulfamethoxazole, Trimethoprim | Sulfamethoxazole Trimethoprim |  | 2005-01-27 |  |  | |
| ANDA Repository | Cefdinir | Cefdinir |  | 2007-07-18 |  |  |
| Cefpodoxime proxetil | Cefpodoxime Proxetil |  | 2007-11-14 |  |  | |
| Ceftriaxone | Ceftriaxone |  | 2017-01-20 |  |  | |
| Cephalexin | Cephalexin |  | 2005-06-28 |  |  |
1
2
3
4
5
6
...
10
>
Clinical Trials
Historical Success Rate
Phase 1
50%2/4
Phase 2
10%1/10
Phase 3
89%25/28
Approved: 17Overall Success rate: 4%
All Clinical Trials
No data
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use